. The FDA Approves Aducanumab for Alzheimer's Disease, Raising Important Scientific Questions1. J Alzheimers Dis. 2021;82(3):881-882. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.